Abstract
Restless leg syndrome (RLS) is a common disorder associated with significant distress. We report three cases of drug induced RLS caused by olanzapine. In each case, RLS commenced after initiation of treatment with olanzapine and resolved after ceasing olanzapine. All three patients were subsequently treated with other atypical antipsychotics, risperidone, quetiapine or aripiprazole, without re-emergence of RLS. RLS is associated with central dopaminergic dysfunction. Dopamine agonists and l-dopa reduce the symptoms of RLS, and some agents that block the dopaminergic system aggravate RLS. Greater awareness of potential causes of RLS, and its differentiation from akathisia and illness related agitation might help in reducing the distress associated with it and improving patient compliance.
Keywords: Restless legs syndrome, olanzapine
Current Drug Safety
Title: Restless Leg Syndrome Associated with Olanzapine: A Case Series
Volume: 5 Issue: 2
Author(s): Shilpa Aggarwal, Seetal Dodd and Michael Berk
Affiliation:
Keywords: Restless legs syndrome, olanzapine
Abstract: Restless leg syndrome (RLS) is a common disorder associated with significant distress. We report three cases of drug induced RLS caused by olanzapine. In each case, RLS commenced after initiation of treatment with olanzapine and resolved after ceasing olanzapine. All three patients were subsequently treated with other atypical antipsychotics, risperidone, quetiapine or aripiprazole, without re-emergence of RLS. RLS is associated with central dopaminergic dysfunction. Dopamine agonists and l-dopa reduce the symptoms of RLS, and some agents that block the dopaminergic system aggravate RLS. Greater awareness of potential causes of RLS, and its differentiation from akathisia and illness related agitation might help in reducing the distress associated with it and improving patient compliance.
Export Options
About this article
Cite this article as:
Aggarwal Shilpa, Dodd Seetal and Berk Michael, Restless Leg Syndrome Associated with Olanzapine: A Case Series, Current Drug Safety 2010; 5 (2) . https://dx.doi.org/10.2174/157488610790936187
DOI https://dx.doi.org/10.2174/157488610790936187 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antibodies as Crypts of Antiinfective and Antitumor Peptides
Current Medicinal Chemistry Neurorestorative Effect of Urinary Bladder Matrix-Mediated Neural Stem Cell Transplantation Following Traumatic Brain Injury in Rats
CNS & Neurological Disorders - Drug Targets The Cerebrospinal Fluid Amyloid β42/40 Ratio in the Differentiation of Alzheimers Disease from Non-Alzheimers Dementia
Current Alzheimer Research Management of Ovarian Cancer In Younger Women
Reviews on Recent Clinical Trials Ribozymes in the Age of Molecular Therapeutics
Current Molecular Medicine DSPE-PEG: A Distinctive Component in Drug Delivery System
Current Pharmaceutical Design Nutrapharmacology of Tocotrienols for Metabolic Syndrome
Current Pharmaceutical Design The Other Side of Opioid Receptor Signalling: Regulation by Protein-Protein Interaction
Current Drug Targets Anesthesia, Calcium Homeostasis and Alzheimers Disease
Current Alzheimer Research Anti-Inflammatory Agents in Parkinsons Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Adolescent Medication Misuse: Results from the MUSC Inventory of Medication Experiences (MIME)
Adolescent Psychiatry Cortical and Putamen Age-Related Changes in the Microvessel Density and Astrocyte Deficiency in Spontaneously Hypertensive and Stroke-Prone Spontaneously Hypertensive Rats
Current Neurovascular Research Myelin Oligodendrocyte Glycoprotein and Multiple Sclerosis
Medicinal Chemistry Psychosocial Stress, Emotions and Cytokine-Related Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Subject Index To Volume 2
Current Nutrition & Food Science Coumarin Derivatives in Pharmacotherapy of Alzheimer´s Disease
Current Organic Chemistry New Therapeutic Drugs from Bioactive Natural Molecules: The Role of Gut Microbiota Metabolism in Neurodegenerative Diseases
Current Drug Metabolism The I.F.A.S.T. Model Allows the Prediction of Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment with High Degree of Accuracy
Current Alzheimer Research Development and Validation of HPLC–PDA Method for the Quantitative Determination of Diphenyl Diselenide in Poly(lactide) Nanoparticles
Current Pharmaceutical Analysis Editorial (Thematic Issue: “Heterocycle and Hydrocarbon Compounds from Natural Sources in Medicinal Chemistry: From Synthesis to Computational Design in Pharmacological Applications” – Part 1)
Current Topics in Medicinal Chemistry